HealthEquity board authorizes new $300M stock repurchase program

HEALTHEQUITY, INC.

Board authorized new $300M stock repurchase program on June 26, 2025.
Program supplements existing $300M program from August 2024; allows opportunistic repurchases.
Repurchases may be made via open market, private transactions, or Rule 10b5-1 plans.
Company not obligated to repurchase any specific amount; program can be suspended anytime.

item 5.07item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.